Latest Hypertension News
One in 4 MI survivors develop heart failure within 4 years.
As elderly patients age, the number of drugs they take that may cause hyperkalemia increases.
Heart groups issue updated guideline for the treatment of heart failure.
The findings warrant reconsideration of blood pressure targets for many patients older than 75, according to an editorial.
African Americans with masked hypertension had 2 times the risk of developing clinic hypertension.
Researchers say restricting sodium might backfire, but heart experts are critical of the finding.
Latest findings from national trial show it lowers chances of heart failure, even in older adults.
Odds increase with rapid rise in middle age.
A patient's short-term fall risk increases in the 15 days after initiation or intensification of antihypertensive medication.
Elevated systolic BP is linked to adverse outcomes in elderly patients.
Treatment with angiotensin-converting enzyme inhibitors was most strongly associated with hyperkalemia.
Treatment linked to improved long-term survival, regardless of underlying kidney function.
The addition of aliskiren to enalapril led to more adverse events in patients with chronic heart failure without an increase in benefit.
More than half of high-risk atrial fibrillation patients are not prescribed oral anticoagulants.
Trajectory data indicate that childhood BP levels correlate with BP status at age 38 years.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)